Prenatal Diagnostics Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Prenatal Diagnostics Market covers analysis By Procedure (Ultrasonography, Chorionic Villus Sampling, Amniocentesis, Percutaneous Umbilical Blood Sampling, Preimplantation Genetic Diagnosis); Product and Services (Instruments, Consumables, Services); Application ( Chromosome Abnormality, Genetic Disorders); End User (Hospitals, Diagnostic Laboratories); , and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00006866
  • Category : Medical Device
  • No. of Pages : 150
Buy Now

Prenatal Diagnostics Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Buy Now

MARKET INTRODUCTION

Prenatal diagnosis is done for the women to prevent the genetic disorders in their babies. During the routine pregnancy period, if the results of blood tests and ultrasound are abnormal then a doctor may ask for the amniocentesis and chorionic villus sampling procedures. The prenatal diagnosis allows to detect the genetic defects and other disorders in the baby and helps parents to take decision of continuing the pregnancy.

MARKET DYNAMICS

The prenatal diagnostics market is estimated to grow due to the driving factors such as rising genetic disorders such as Down syndrome, sickle cell disease and others. The market is expected to grow due to the rising genetic based research, increasing genetic diagnosis, growing birth rate and others. The market is expected to have several growth opportunities in the emerging and developing regions where the population is growing exponentially.

MARKET SCOPE

The "Global Prenatal Diagnostics Market Analysis to 2028" is a specialized and in-depth study of the medical device industry with a special focus on the global market trend analysis. The report aims to provide an overview of prenatal diagnostics market with detailed market segmentation by procedure, product & services, application and end user and geography. The global prenatal diagnostics market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading prenatal diagnostics market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The global prenatal diagnostics market is segmented on the basis of procedure, product & services, application and end user. Based on the procedure the market is segmented as ultrasonography, chorionic villus sampling, amniocentesis, percutaneous umbilical blood sampling, and preimplantation genetic diagnosis. On the basis of product & services the market is classified as instruments, consumables, and services. Based on the application the market is segmented as chromosome abnormality, and genetic disorders. On the basis of end user the market is categorized as hospitals, diagnostic laboratories.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global prenatal diagnostics market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The prenatal diagnostics market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting prenatal diagnostics market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the prenatal diagnostics market in these regions.

Prenatal Diagnostics Market Report Analysis

Prenatal Diagnostics Market

  • CAGR (2023 - 2031)
    XX%
  • Market Size 2023
    US$ XX Million
  • Market Size 2031
    US$ XX Million

Report Coverage

  • Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
  • Key future trends
  • Detailed PEST/Porter’s Five Forces and SWOT analysis
  • Industry landscape and competition analysis & recent developments
  • Detailed company profiles
  • Global and regional market analysis covering key market trends, major players, regulations, and recent market developments

Key Players

  • GE Healthcare (General Electric Company)
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • F. Hoffman-La Roche Ltd.
  • Beijing Genomics Institute
  • Agilent Technologies, Inc.
  • Perkinelmer, Inc.
  • Hologic, Inc.
  • Natera, Inc.

Regional Overview

  • North America
  • Europe
  • Asia-Pacific
  • South and Central America
  • Middle East and Africa

Market Segmentation

By Procedure
  • Ultrasonography
  • Chorionic Villus Sampling
  • AMillioniocentesis
  • Percutaneous Umbilical Blood Sampling
  • Preimplantation Genetic Diagnosis
By Product and Services
  • Instruments
  • Consumables
  • Services
By Application
  • Chromosome ABillionormality
  • Genetic Disorders
By End User
  • Hospitals
  • Diagnostic Laboratories
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
MARKET PLAYERS


The reports cover key developments in the prenatal diagnostics market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from prenatal diagnostics market are anticipated to lucrative growth opportunities in the future with the rising demand for prenatal diagnostics market in the global market. Below mentioned is the list of few companies engaged in the prenatal diagnostics market.

The report also includes the profiles of key prenatal diagnostics market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  GE Healthcare (General Electric Company)
  •  Thermo Fisher Scientific, Inc.
  •  Illumina, Inc.
  •  F. Hoffman-La Roche Ltd.
  •  Beijing Genomics Institute
  •  Agilent Technologies, Inc.
  •  Perkinelmer, Inc.
  •  Hologic, Inc.
  •  Natera, Inc.
  •  Quest Diagnostics, Inc.
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Prenatal Diagnostics Market Report Scope

Report Attribute Details
Market size in 2023 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Procedure
  • Ultrasonography
  • Chorionic Villus Sampling
  • AMillioniocentesis
  • Percutaneous Umbilical Blood Sampling
  • Preimplantation Genetic Diagnosis
By Product and Services
  • Instruments
  • Consumables
  • Services
By Application
  • Chromosome ABillionormality
  • Genetic Disorders
By End User
  • Hospitals
  • Diagnostic Laboratories
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • GE Healthcare (General Electric Company)
  • Thermo Fisher Scientific, Inc.
  • Illumina, Inc.
  • F. Hoffman-La Roche Ltd.
  • Beijing Genomics Institute
  • Agilent Technologies, Inc.
  • Perkinelmer, Inc.
  • Hologic, Inc.
  • Natera, Inc.
    • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
    Report Coverage
    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered
    Segment Covered

    This text is related
    to segments covered.

    Regional Scope
    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope
    Country Scope

    This text is related
    to country scope.

    The List of Companies

    1. GE Healthcare (General Electric Company)2. Thermo Fisher Scientific, Inc.3. Illumina, Inc.4. F. Hoffman-La Roche Ltd.5. Beijing Genomics Institute6. Agilent Technologies, Inc.7. Perkinelmer, Inc.8. Hologic, Inc.9. Natera, Inc.10. Quest Diagnostics, Inc.

    Trends and growth analysis reports related to Medical Device : READ MORE..